Literature DB >> 17655868

Is brain lactate increased in Huntington's disease?

W R Wayne Martin1, Marguerite Wieler, Christopher C Hanstock.   

Abstract

Impaired brain energy metabolism with increased regional brain lactate may play a role in the pathogenesis of Huntington's disease (HD). Magnetic resonance spectroscopy (MRS) has provided conflicting evidence, however, regarding metabolic changes. Our objective was to evaluate the potential contribution of CSF lactate to the changes observed with MRS in HD. We performed single voxel MRS at 3 T in 23 patients with HD and 28 age-matched control subjects using a method to segment voxels into grey matter, white matter, and CSF, and to extrapolate regional lactate content to a hypothetical voxel containing 100% brain in order to control for differences in CSF lactate. Lactate/creatine and lactate/N-acetyl aspartate (Lac/NAA) ratios were significantly increased in parieto-occipital (p<0.05) and cerebellar (p<0.01) voxels in HD patients. After extrapolating group Lac/NAA results to a theoretical voxel containing 100% brain, this ratio was greater in the HD group than the control group, suggesting possibly increased lactate in this predicted voxel, although the difference between groups did not reach statistical significance. These results suggest an increase in brain lactate content in manifest HD, in a regionally non-specific fashion, although the possibility of a CSF contribution to this increase cannot be ruled out. Regardless, this supports the possibility of impaired mitochondrial function resulting in abnormal brain energy metabolism in HD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655868     DOI: 10.1016/j.jns.2007.05.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.

Authors:  Luana Naia; I Luísa Ferreira; Teresa Cunha-Oliveira; Ana I Duarte; Márcio Ribeiro; Tatiana R Rosenstock; Mário N Laço; Maria J Ribeiro; Catarina R Oliveira; Frédéric Saudou; Sandrine Humbert; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2014-05-20       Impact factor: 5.590

2.  Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease.

Authors:  T M Tsang; J N Haselden; E Holmes
Journal:  Neurochem Res       Date:  2009-01-16       Impact factor: 3.996

Review 3.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

4.  Oxidative stress and plasma aminopeptidase activity in Huntington's disease.

Authors:  Raquel Duran; Francisco J Barrero; Blas Morales; Juan D Luna; Manuel Ramirez; Francisco Vives
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

5.  IGF-1 intranasal administration rescues Huntington's disease phenotypes in YAC128 mice.

Authors:  Carla Lopes; Márcio Ribeiro; Ana I Duarte; Sandrine Humbert; Frederic Saudou; Luís Pereira de Almeida; Michael Hayden; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2013-12-18       Impact factor: 5.590

Review 6.  Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Miles R Bryan; Aaron B Bowman
Journal:  Adv Neurobiol       Date:  2017

7.  Low anaerobic threshold and increased skeletal muscle lactate production in subjects with Huntington's disease.

Authors:  Andrea Ciammola; Jenny Sassone; Monica Sciacco; Niccolò E Mencacci; Michela Ripolone; Caterina Bizzi; Clarissa Colciago; Maurizio Moggio; Gianfranco Parati; Vincenzo Silani; Gabriella Malfatto
Journal:  Mov Disord       Date:  2010-10-07       Impact factor: 10.338

Review 8.  Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling.

Authors:  Pooja Jadiya; Joanne F Garbincius; John W Elrod
Journal:  Acta Neuropathol Commun       Date:  2021-07-07       Impact factor: 7.801

9.  Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease.

Authors:  Caroline Gouarné; Gwenaëlle Tardif; Jennifer Tracz; Virginie Latyszenok; Magali Michaud; Laura Emily Clemens; Libo Yu-Taeger; Huu Phuc Nguyen; Thierry Bordet; Rebecca M Pruss
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

10.  Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis.

Authors:  Nashwah Ismail; Nina Kureishy; Stephanie J Church; Melissa Scholefield; Richard D Unwin; Jingshu Xu; Stefano Patassini; Garth J S Cooper
Journal:  Biochem Biophys Res Commun       Date:  2019-11-20       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.